PURPOSE: Surgical management of pediatric vesicoureteral reflux (VUR) aims to reduce febrile urinary tract infections (fUTIs) while minimizing perioperative morbidity. We compared dextranomer/hyaluronic acid (Dx/HA) injection with ureteral reimplantation, focusing on durability, infectious outcomes, and perioperative burden. METHODS: and bias with RoB 2.0/ROBINS-I. RESULTS: =1.12). Evidence certainty was limited by heterogeneity and predominantly non-randomized data. CONCLUSIONS: Ureteral reimplantation has lower likelihood of reoperation and with possibly postoperative UTI risk, while Dx/HA offers meaningful perioperative advantages. These trade-offs support individualized, risk-adapted surgical decision-making for pediatric VUR.
Kim et al. (Tue,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: